Journal of Natural Products · 2018 · 54 citations · 19 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryOrganic ChemistryStructure-activity RelationshipsHeterocyclic ChemistryNatural Product Drug DiscoveryStructure-activity Relationship AnalysisTerpenoid BiosynthesisBioactive Compound LibrariesBioactive HeterocyclesMedicinal Chemistry ApplicationsMedicinal HeterocyclesQuantum Chemical ModelingQuinone Biosynthesis
Eight enantiomeric pairs of new meromonoterpenoids (1a/1b–8a/8b) and four known compounds (9–12) were isolated from Rhododendron nyingchiense. Their structures were established by spectroscopic methods, quantum chemical calculations, and X-ray crystallography. The enantiomeric pairs were acquired from scalemic mixtures by chiral-phase HPLC and showed diverse heterocyclic frameworks. Compounds 1a/1b possess a rare 6/7/5/5 heterocyclic system, and 2a/2b incorporate a new 6/6/3/5 heterocyclic system featuring a quinone motif. Compounds 3a/3b represent the first meroterpenoids with a 6/6/5 ring system from the Rhododendron genus. Putative biosynthetic pathways of these compounds are proposed. Compounds 1b, 2a–4a, 8a, 8b, and 11 exhibited weak inhibitory effects on PTP1B, with IC50 values ranging from 5.7 ± 0.5 to 61.0 ± 4.8 μM.
19
Antinociceptive Grayanoids from the Roots of <i>Rhododendron molle</i>
Yong Li, Yun‐Bao Liu, Jianjun Zhang et al. · Journal of Natural Products · 2015 · 88 citations
Anti-inflammatory Grayanane Diterpenoids from the Leaves of <i>Rhododendron molle</i>
Junfei Zhou, Tingting Liu, Hanqi Zhang et al. · Journal of Natural Products · 2017 · 83 citations
Life Sciences, Botany, Chemistry +16